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Abstract. 
 
Kinesin superfamily proteins (KIFs) com-
prise several dozen molecular motor proteins. The 
KIF3 heterotrimer complex is one of the most abun-
dantly and ubiquitously expressed KIFs in mammalian 
cells. To unveil the functions of KIF3, microinjection of 
function-blocking monovalent antibodies against KIF3 
into cultured superior cervical ganglion (SCG) neurons 
was carried out. They signiﬁcantly blocked fast axonal 
transport and brought about inhibition of neurite ex-
tension. A yeast two-hybrid binding assay revealed the 
association of fodrin with the KIF3 motor through 
KAP3. This was further conﬁrmed by using vesicles col-
lected from large bundles of axons (cauda equina), 
from which membranous vesicles could be prepared in 
pure preparations. Both immunoprecipitation and im-
munoelectron microscopy indicated the colocalization 
of fodrin and KIF3 on the same vesicles, the results re-
inforcing the evidence that the cargo of the KIF3 motor 
consists of fodrin-associating vesicles. In addition, 
pulse-labeling study implied partial comigration of both 
molecules as fast ﬂow components. Taken together, the 
KIF3 motor is engaged in fast axonal transport that 
conveys membranous components important for neu-
rite extension. 
Key words: kinesin superfamily protein 3 • fodrin • 
microinjection • axonal transport • yeast two-hybrid
 
Introduction
 
The neuron is an example of a highly differentiated cell
whose structure embodies its inherent manifold functions.
The fine arborization of the dendrites and axons of neu-
rons is adapted to the information processing taking place
in the cell body. Due to the extreme specialization of the
axon for transport, it is devoid of the machinery required
for protein synthesis, which is an essential prerequisite for
maintenance of the structures and functions of the axons
and synapses. To deliver the required materials to the syn-
apse, the neuron has a specialized machinery for axonal
transport, where two major cytoskeletal structures (mi-
crofilaments and microtubules) serve as tracks. Microtu-
bules (MTs)
 
1
 
 are considered to play major roles in long-
distance transport, whereas actin filaments are believed to
be responsible for relatively short distance trafficking.
During the past decade, subsequent to the discovery of ki-
nesin (Brady, 1985; Vale et al., 1985) as a motor protein,
several unique MT-dependent motor proteins have been
identified and characterized in various living species. The
kinesin superfamily proteins (KIFs; Aizawa et al., 1992;
Hirokawa, 1996, 1998) are a collection of such motor pro-
teins, most of which work as motors for anterograde trans-
port along the MTs to their plus ends.
The KIF3 motor is one of the most abundantly and
ubiquitously expressed KIFs, predominantly found in the
nervous system. It is composed of a heterotrimeric com-
plex formed with KIF3A (Aizawa et al., 1992; Kondo et al.,
1994), either KIF3B (Yamazaki et al., 1995) or KIF3C
(Muresan et al., 1998; Yang and Goldstein, 1998), and an
associated protein, KAP3 (Yamazaki et al., 1995, 1996).
This protein complex also has phylogenic diversity, blan-
keting a broad range of organisms from the sea urchin (ki-
nesin II; Cole et al., 1993), 
 
Chlamydomonas reinhardtii
 
(FLA10; Walther et al., 1994), 
 
Caenorhabditis elegans
 
(Cekinesin II; Signor et al., 1999), 
 
Drosophila melano-
gaster 
 
(KLP68D; Pesavento et al., 1994), 
 
Xenopus laevis
 
(Xklp3; Le Bot et al., 1998), and 
 
Rana rugosa
 
 (mKIF3A;
Nakajima et al., 1997), to the green sunfish (
 
Lepomis cy-
 
Address correspondence to Nobutaka Hirokawa, Department of Cell Bi-
ology and Anatomy, University of Tokyo, Graduate School of Medicine,
 
7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. Tel.: 
 
1
 
81-3-5841-3326.
Fax:
 
1
 
81-3-5802-8646. 
 
1
 
Abbreviations used in this paper:
 
 aa, amino acids; CyDy, cytoplasmic
dynein; KIF, kinesin superfamily protein; MT, microtubule; SCG, supe-
rior cervical ganglion. 
The Journal of Cell Biology, Volume 148, 2000 1256
 
anellus 
 
photoreceptor KIF3 antigen; Beech et al., 1996),
implying its importance. The results of our previous study
(Yamazaki et al., 1995) provided morphological evidence
of the association of KIF3 with vesicles 90–160 nm in di-
ameter that are biochemically isolated from the large bun-
dles of axons (cauda equina) in the rat. Furthermore, sev-
eral recent papers have reported the localization of KIF3
in greater detail, namely, that the KIF3 motor is installed
within cilioflagellar structures, such as the connecting cilia
of retinal rod cells (Muresan et al., 1997), embryonal sea
urchin cilia (Morris and Scholey, 1997), and 
 
Chlamydomo-
nas
 
 flagella (Kozminski et al., 1995; Cole et al., 1998;
Rosenbaum et al., 1999). Surprisingly, the latest knockout
studies on KIF3A (Marszalek et al., 1999; Takeda et al.,
1999) and KIF3B (Nonaka et al., 1998) revealed the im-
portance of KIF3 for left–right determination through cil-
iogenesis of nodal cells. Furthermore, it was demonstrated
that the nodal cilia, in which KIF3A/B are localized, are
rotating to generate unidirectional flow of extraembryonic
fluid (nodal flow), which fundamentally controls left–right
determination (Nonaka et al., 1998; Takeda et al., 1999).
Although the functions of the KIF3 family in nonneu-
ronal systems have been intensively studied in various
kinds of cells (Aizawa et al., 1992, Kondo et al., 1994;
Yamazaki et al., 1995, 1996; Muresan et al., 1997; Cole et al.,
1998; Le Bot et al., 1998; Nonaka et al., 1998; Tuma et al.,
1998; Marszalek et al., 1999; Takeda et al., 1999), there re-
main large frontiers for us to reveal the function of KIF3
in neurons since it is abundantly expressed in the nervous
system (Aizawa et al., 1992; Kondo et al., 1994; Pesavento
et al., 1994; Yamazaki et al., 1995). Recent evidence sug-
gested that 
 
Drosophila
 
 homologues of KIF3, i.e., KLP64D
and KLP68D, are expressed in cholinergic neurons and
are engaged in the axonal transport of choline acetyl trans-
ferase (Ray et al., 1999), although the functions of verte-
brate KIF3 have not been elucidated yet. In the present
study, we microinjected a monovalent Fab fragment of the
anti-KIF3B antibody, which functionally hampers the mo-
tility of KIF3A/B heterodimers, into the cultured superior
cervical ganglion (SCG) neurons to monitor the function
of KIF3 motor in neuron. Furthermore, to investigate the
results of microinjection experiments and to determine the
way of cargo-binding of KIF3 motor, yeast two-hybrid
binding assay was carried out. Subsequently, the physio-
logical relevance of the obtained clones were examined
by the combination of strategies, such as immunopre-
cipitation, immunoelectron microscopy, and pulse-label-
ing study.
 
Materials and Methods
 
Cell Culture of SCG Neurons
 
The culture of SCG neurons was carried out according to Takenaka et al.
(1992), with slight modifications. In brief, C57BL mice aged 4–6 wk were
killed by deep narcosis using diethyl ether. We cut open the neck region to
reach the SCG, located just beneath the region where the common carotid
artery branches into the external and internal carotid artery. The extir-
pated pairs of SCGs were briefly rinsed, cut into small pieces with a surgi-
cal blade, and bathed in HBSS. We incubated these small pieces in 1%
trypsin (Sigma Chemical Co.) for 1 h, and then subjected them to 1% col-
lagenase digestion (Worthington Biomedical Co.) for 3 h. During both en-
zymatic digestion procedures, the plastic tubes containing the tissue pieces
were shaken in an air incubator heated at 37
 
8
 
C, to facilitate dissociation.
 
Finally, we gently triturated the small SCG pieces after adding culture me-
dia for neutralizing the enzymes. The dissociated cells were plated on cov-
erslips coated with collagen type IV (Sigma Chemical Co.) overlaid on
poly-
 
D
 
-lysine, and grown in serum-free media to obtain unipolar neurons
(Higgins et al., 1991).
 
Antibody Characterization and Fab Preparation
 
In the present work, we prepared Fab fragments from an affinity-purified
anti-KIF3B antibody (Yamazaki et al., 1995), and from chromatographi-
cally purified normal mouse IgG (Zymed Labs) as a control. For obtain-
ing the Fab fragments, we used the Fab preparation kit (Pierce Chemical
Co.) according to the manufacturer’s instructions. The resultant purified
Fabs were concentrated to 
 
z
 
4 mg/ml by ultrafiltration (CENTRICON;
Pharmacia Biotech), and dialyzed against potassium (K) glutamate injec-
tion buffer (50 mM potassium glutamate, 100 mM KCl, and 1 mM MgCl
 
2
 
,
pH 6.8) as described elsewhere (Funakoshi et al., 1996). The purity of Fab
was confirmed by SDS gel electrophoresis. For the microinjection, we di-
luted the concentrated Fabs with K-glutamate buffer containing fluores-
cently labeled BSA to 3 mg/ml. Other antibodies used in this study were
commercially available or developed by us: anti–
 
a
 
II-fodrin antibody (Bio-
genesis Ltd.); anti-KIF1A (Okada et al., 1995b); anti-KAP3 antibody
(Yamazaki et al., 1996); anti-KIF5A antibody (Kanai, Y., Y. Okada, Y.
Tanaka, A. Harada, S. Terada, and N. Hirokawa, manuscript in prepara-
tion); and anti-KIF5B antibody (Kanai, Y., Y. Okada, Y. Tanaka, A.
Harada, S. Terada, and N. Hirokawa, manuscript in preparation).
 
Immunofluorescence Microscopy and Western Blotting 
of SCG
 
The immunofluorescence study of SCG cells was performed as described
previously (Takeda et al., 1994) with minor changes (Muresan et al.,
1998). The preparations were observed by BioRad confocal laser scanning
microscopy. We also carried out Western blotting using the procedure
previously described (Takeda et al., 1999).
 
Microinjection of Fab into SCG Cells
 
We microinjected the above mentioned anti-KIF3B Fab or normal mouse
IgG Fab into the cultured SCG neurons at a concentration of 
 
z
 
3 mg/ml,
as described previously (Brady et al., 1990; Takeda et al., 1994, 1995). As
we reported previously (Yamazaki et al., 1995), this anti-KIF3B antibody
specifically blocks the motility of KIF3A/B heterodimers in a concentra-
tion-dependent manner. For the identification of the injected cells, we
coinjected fluorescein-labeled BSA (Takeda et al., 1994). For the vesicle
traffic assay, the microinjections were carried out into SCG neurons with
mature single axons displaying a relatively flat morphology and firmly at-
tached to the substrate (
 
z
 
2 d after plating), for ease of observing the vesi-
cle traffic by VEC–DIC microscopy. In this case, the concentration of an-
tibody within the neurons is calculated to be 0.1–0.2 mg/ml, provided that
the injected volume is 10
 
2
 
10
 
 ml (Okabe and Hirokawa, 1988) and the vol-
ume of neurons is 4 
 
3
 
 10
 
2
 
9
 
 ml (provided that the cell bodies of the neu-
rons used in our experiment have a diameter of 
 
z
 
20 
 
m
 
m and height of
 
z
 
10 
 
m
 
m, the axons being 2 
 
m
 
m in diameter and 600 
 
m
 
m in length). Since
the Fab fragments have a molecular weight of about one-third that of na-
tive IgG, their molar concentration within the neuron should be at least
0.3–0.6 mg/ml, the value being higher than the minimal concentration re-
quired to completely block the motility of KIF3 in vitro. For the neurite
extension inhibition assay, we selected neurons without neurites for mi-
croinjecting the antibodies (
 
z
 
12–20 h after plating), so that the concentra-
tion became much higher (at least twofold higher than that in the vesicle-
blocking study) in this case.
 
Observation and Data Collection
 
An Olympus IX-70 microscope (Olympus Optics Co.) equipped with
VEC–DIC/FL gadgetry was used for observing and recording the vesicle
traffic within axons (Okada et al., 1995a). The entire microscope was in-
stalled inside a plastic chamber in which the temperature was controlled
to 
 
z
 
37
 
8
 
C (Takenaka et al., 1992) using a thermostat. We repeated each
pair of experiments seven times independently on different days. Each
session consisted of 5–7 experimental runs, where microinjected neurons
that were viable and appeared normal were chosen randomly for VEC–
DIC observation. For the control experiment, we took records of 35 cells,
whereas for the anti-KIF3 Fab series, 32 neurons were recorded. Each ob- 
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servation was videotaped for 5 min. Vesicular structures moving both cen-
trifugally and centripetally were captured in the same video frames. Con-
sidering the demilune shape of an axonal cross-section, the volume of
organelle traffic was calibrated by the cross-sectional area of the axon.
Therefore, the ordinate in Fig. 5 indicates the number of vesicles passing
through one square micrometer of the axon (
 
z
 
200–400 
 
m
 
m downstream
from the cell body) per 5 min. For the neurite sprouting inhibition assay,
the neurite lengths of cells identified under the fluorescence microscope
were measured 
 
z
 
12 h after microinjection of Fabs. In brief, the cells
grown on coverslips were fixed with 2% paraformaldehyde, mounted on
glass slides, and photographed. Measurement of neurite length was per-
formed on these photographs. We observed 60 cells injected with anti-
KIF3B Fab and 50 injected with control IgG Fab. Each experimental ses-
sion consisted of 5–6 independent experimental trials. We used 
 
t
 
 tests
to compare the mean value of the vesicle in anti-KIF3B Fab-injected
group with that of the control group. The level of significance was set at
 
P 
 
, 
 
0.05.
 
Construction of cDNA Libraries for Yeast
Two-Hybrid Screening
 
Mouse total brain RNA was prepared from 5-d-old ICR pups using the
Total RNA Separator Kit (Clontech), followed by isolation of mRNA
from this preparation with the aid of the mRNA Separator Kit (Clon-
tech). Then, cDNA libraries were prepared using the SuperScript choice
system (GibcoBRL) with random hexamer primers. The cDNA library
was ligated with EcoRI/NotI/SalI adaptors and inserted into the
pBD42AD vector. We transformed ElectroMAX DH10B cells (Gibco-
BRL) with this construction and in turn obtained 6 
 
3
 
 10
 
6
 
 indepen-
dent clones. Finally, the plasmids were purified using the QUIAGEN
Plasmid Kit.
 
Screening of KAP3-binding Proteins by Yeast
Two-Hybrid Assay
 
A Matchmaker LexA two-hybrid system was used for the screening ac-
cording to the instructions provided by the manufacturer (Clontech).
In brief, a part of the KAP3 gene (amino acids [aa] 209–384, containing
arm repeats 2–4) was fused to the DNA-BD region of the pLexA vector
by the PCR method. Then the plasmid was cotransfected with the above
mentioned library plasmids into the yeast strain EGY48 carrying the
p8op-lacZ gene, grown on a SD/
 
2
 
His/
 
2
 
Trp/
 
2
 
Ura plate supplemented
with glucose. Selection of positive clones was performed on a SD/
 
2
 
His/
 
2
 
Trp/
 
2
 
Ura/
 
2
 
Leu plate containing galactose/raffinose/X-gal/BU salts.
Subsequent to these procedures, the bait plasmids were recovered from
the positive clones to confirm whether the observed interaction was genu-
ine, by retransformation into the yeast. We repeated these procedures
several times and analyzed their sequences for which interaction was re-
producibly ascertained.
 
b
 
-Galactosidase Activity in Liquid Cultures of Yeast
 
The 
 
b
 
-galactosidase activity in liquid cultures of yeast was assayed as de-
scribed previously (Ausubel et al., 1997). In brief, mid-log phase yeast
cells were collected and permeabilized with 0.1% sodium dodecyl sul-
phate (SDS) and chloroform. The chromogenic substrate o-nitrophenyl-
 
b
 
-
 
D
 
-galactoside was added in excess to this lysate, and after incubation at
30
 
8
 
C, the reaction was stopped by increasing the pH to 11, by the addition
of 1 M Na
 
2
 
CO
 
3
 
. The OD at 420 nm, which corresponds to the absorbance
by the reaction product, o-nitrophenol, was determined by spectropho-
tometry and normalized to the reaction time and the cell density.
 
Preparation and Immunoprecipitation of Vesicular 
Components from the Rat Cauda Equina 
 
The preparation of cauda equina vesicles was carried out according to a
previously reported method (Okada et al., 1995b), with slight modifica-
tions. In brief, two sets of cauda equina extirpated from dead female SD
rats were put into 1 ml of IM-D buffer, supplemented with a protease in-
hibitor cocktail (Sigma Chemical Co.) and 1 mM ATP, and minced with a
pair of ophthalmological scissors for 5 min. After 5-min incubation on ice,
they were minced again for 5 min. Under this condition, KIF motor pro-
teins became detached from the MTs, enabling us to isolate the vesicles
harboring KIFs. In addition, contamination of axolemmal components
could be avoided, as the samples were never homogenized. The resultant
suspension was subjected to centrifugation at 10,000 rpm for 10 min at
Kubota’s benchtop centrifugator, to eliminate gross fragments of the ax-
onal sheath. The obtained supernatant, rich in axonal vesicles, was used
for further analysis.
For immunoprecipitation, protein A–Sepharose beads (Pharmacia Bio-
tech) were coupled with either anti-KIF3B, KAP3, 
 
a
 
-fodrin, or preim-
mune serum as described previously (Okada et al., 1995b). In brief, poly-
clonal antibodies against KAP3, KIF1A (1 mg each), and mAb against
 
a
 
II-fodrin (1 mg) were bound to 15 ml of fresh protein A–Sepharose 4B
beads (Pharmacia Biotech) in TBS containing 1% Triton X-100 (TBST)
for 2 h at 4
 
8
 
C before the immunoprecipitation. Uncoupled antibody was
removed by washing the beads five times in TBST. The above mentioned
vesicle fractions were incubated overnight with antibody-coupled Seph-
arose beads, and thoroughly washed three times with IM-D. Then the
beads were incubated with IM-D containing 1% Triton X-100 for 1 h on
ice, followed by washing with IM-D twice. Finally, the obtained beads
were processed for SDS gel electrophoresis, transferred to a membrane,
and prepared for Western blotting.
 
Negative Staining of the Cauda Equina Vesicles
 
The cauda equina vesicles prepared as above were subjected to immuno-
electron microscopy and negative staining according to the method re-
ported by Nishiye et al. (1988), with slight modifications (Takeda et al.,
1994). After random observation and electron microscopic photography
(JEOL 1200Ex), the frequency of the colocalization of gold-labeling for
KIF3B and fodrin was determined as follows. We categorized the parame-
ter into the following three sections: single-labeling with either anti-
KIF3B antibody or anti–
 
a
 
II-fodrin antibody; double-labeling with both
anti–
 
a
 
II-fodrin and anti-KIF3B antibodies; and control normal mouse
IgG/preimmune serum. The labeling frequency was calculated by dividing
the total number of vesicles with that of vesicles harboring colloidal gold.
Then, the obtained values were calibrated with that of negative control. 38
pictures containing 454 vesicles were quantified for their labeling fre-
quency. The background colloidal gold per cm
 
2
 
 (colloidal gold signals that
did not associate with vesicles) was also calculated, and it was subtracted
from the frequency of labeling. About 54% of all vesicles were labeled
with either anti-fodrin antibody or anti-KIF3B antibody.
 
Immunoelectron Microscopy of the Mouse Cauda 
Equina Vesicles
 
Immunoelectron microscopy of the biochemically purified cauda equina
vesicles was carried out according to the method reported by De Camilli
et al. (1983). In brief, a small aliquot (50 ml) of the cauda equina prepara-
tion (Okada et al., 1995b) was mixed with a solution of 
 
z
 
2% agarose in an
Eppendorf tube at 37
 
8
 
C, followed by immediate placement on ice. Solidi-
fied agarose gel was carefully detached from the tube and cut into small
pieces with a surgical blade. These agarose blocks containing the fixed
cauda equina vesicles were further processed for immunoelectron micros-
copy as described previously (Takeda et al., 1994), with modifications in
the incubation times. For the first antibody, the agarose blocks were incu-
bated for 24 h at 4
 
8
 
C with gentle shaking. Since the colloidal gold-conju-
gated second antibody does not easily penetrate into the agarose mesh-
work, we incubated the agarose block for 
 
z
 
2 d at 4
 
8
 
C, rotating the
reaction tube of agarose blocks. After postfixing with half Karnovsky so-
lution and 1% OsO
 
4
 
, the samples were stained overnight with 1% uranyl
acetate, and then completely dehydrated. Finally, they were embedded in
epoxy resin. Ultrathin sections of these blocks were cut and observed by
JEOL 1200Ex.
 
Pulse–Chase of KIF3B by Metabolic-labeling in the Rat 
Optic Nerve
 
The velocities of motor proteins in vivo and the transport of fodrin were
measured according to Elluru et al. (1995). In brief, 1 mCi/4ml of an
[
 
35
 
S]methionine and [
 
35
 
S]cystein mixture (New England Nuclear Life Sci-
ence Products) was injected into the vitreous of the SD rat eyeball (12-wk-
old, male). The animals were killed 4, 6, and 8 h after injection for all the
experiments, except those on KIF1A. For the KIF1A experiment, we col-
lected samples 1.6, 2, and 3 h after injection. The optic tract was extirpated
en bloc and was divided into proximal (5–10 mm from eyeball) and distal
(10–15 mm idem) parts.
Next, all the segments were homogenized in 300 
 
m
 
l of axon lysis buffer
(50 mM NaCl, 25 mM Tris, pH 8.1, 0.5% Triton X-100, 0.5% sodium 
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deoxycholate, 2 mM sodium orthovanadate, 50 mM NaF, 100 mM KPO
 
4
 
,
25 mM sodium pyrophosphate, 80 mM 
 
b
 
-glycerophosphate, 1 mM PMSF,
10 
 
m
 
g/ml pepstatin A, 2 
 
m
 
g/ml aprotinin, 4.5 mM EDTA, 1 mM benzami-
dine, and 10 
 
m
 
g/ml leupeptin), using a polytron microhomogenizer. The
homogenate was then centrifuged at 15,000 rpm for 10 min at 4
 
8
 
C and the
supernatant (S1) was collected (crude extract; this sample was also sub-
jected to SDS-PAGE analysis).
The antibody-conjugated beads were added to S1, and the mixture was
left to stand for 3–4 h at 4
 
8
 
C. After the reaction, the beads were washed
five times with TBST. Finally, each sample was processed by conventional
SDS-PAGE. The gels were dried, exposed to a fluorogram, and read using
a digitized image analyzer (Fuji Bas).
 
Results
 
Characterization of Anti-KIF3B Antibody
 
As previously reported, our anti-KIF3B antibody revealed
binding uniquely with the 85-kb polypeptide in SCG ex-
tracts (Fig. 1 D, lane 1), while preimmune sera did not
(Fig. 1 D, lane 2). Immunofluorescence of cultured SCG
neurons (Fig. 1 A) also revealed the localization of this
protein, both in the cell body and the axons, the latter of
which partly showed a punctate staining pattern (Fig. 1 C).
With the previous ultrastructural finding that KIF3 is asso-
ciated with vesicles isolated from cauda equina (Yamazaki
et al., 1995), this staining pattern is considered to represent
the association of KIF3 with axonal membranous compo-
nents. As shown in our previous study (Yamazaki et al.,
1995), this anti-KIF3B antibody blocks the in vitro motility
of KIF3A/B heterodimers in a concentration-dependent
manner.
 
Reduction of Fast Axonal Transport after Anti-KIF3B 
Fab Injection
 
To test the consequence of inhibiting KIF3 function, Fab
fragments prepared from either anti-KIF3B antibody or
normal mouse IgG (
 
z
 
3 mg/ml) were injected. To avoid
possible cross-linking of vesicles to one another, resulting
in a nonspecific traffic jam, Fab fragments were used.
About three hours after microinjection, we observed the
SCG neurons emitting dim green fluorescence under the
low-light level fluorescence microscope system equipped
with the VEC–DIC system. Under the VEC–DIC, the ra-
tio of the different categories of vesicles did not seem to
have changed as a result of antibody injection (Fig. 2), but
the number of vesicle passing through a certain point on
the axon distant from the cell body (
 
z
 
200–400 mm) was
significantly decreased (Fig. 2). Vesicle movements were
quantified (Fig. 3 C), revealing that the microinjection
process, per se, did not seem to have any deleterious effect
on vesicle traffic, as injection of the control antibody gave
almost the same results, as compared to uninjected sam-
ples (except for mitochondria, all groups show comparable
vesicle traffic to the noninjected group). However, anti-
KIF3B antibody injection dramatically diminished the to-
tal vesicle traffic along axons (Figs. 2 A and 3 B, control,
29.0
 
 6 
 
0.3; anti-KIF3B Fab, 9.4
 
 6 
 
0.1, mean
 
 6 
 
SEM). In
particular, the anterograde traffic (control, 13.7
 
 6 
 
0.2;
anti-KIF3B Fab, 3.8
 
 6 
 
0.1; 27.5% of noninjected group)
was more severely affected than that of retrogradely mov-
ing vesicles (control, 15.3
 
 6 
 
0.2; anti-KIF3B Fab, 5.6
 
 6 
 
0.2;
35.8% of noninjected control), the results reflecting the
nature of KIF3 as an anterograde motor. Since mitochon-
dria did not often move and were only infrequently ob-
served in the SCG, it was difficult to judge whether mito-
chondrial traffic (control, 1.8
 
 6 
 
0.1; anti-KIF3B Fab, 1.0
 
 6
 
0.1) was influenced or not. However, 
 
t
 
 test revealed no sig-
nificant difference in mean values at the significance of
 
P 
 
, 
 
0.05, whereas other groups were significantly different
at the level of
 
 P 
 
, 
 
0.001. In addition, in COS cells or em-
bryonic Reichert’s membrane cells enriched in mitochon-
dria, we could not observe any inhibitory effects of anti-
Figure 1. Characterization of
anti-KIF3B antibody. A, Flu-
orescence immunocytochem-
ical staining of cultured SCG
neurons. Staining with anti-
KIF3B antibody can be ob-
served throughout the neu-
ron, and is especially evident
in axons. When viewed at
higher magnification (C), a
punctate staining pattern,
suggestive of vesicular com-
ponents, was also noted. B,
DIC image of the same cell.
D, Western blotting of mouse
SCG extract probed with the
anti-KIF3B antibody (lane
1). A single distinct band ap-
pears at a height correspond-
ing to that of KIF3B, whereas
no band is seen with preim-
mune serum (lane 2). Bars:
(A and B) 20 mm; (C) 1 mm.
Molecular weight bars in D
(from top to bottom): 200,
116, 97, and 65 kD. 
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body injection on the mitochondrial motility (data not
shown). Thus, we consider that this decreased traffic re-
sulting from anti-KIF3B Fab injection was due to specific
effects exerted on only vesicles transported by the KIF3
motor. Considering the resolution limit of the VEC–DIC
 
system, it was almost impossible to discriminate and clas-
sify each vesicle by size. Therefore, we could categorize vi-
sually observed vesicles into only two groups: large and
bright, or small and dark, which might represent endoso-
mal vesicles and small membranous vesicles, respectively,
as the former tend to move centripetally.
 
Neurite Extension Was Inhibited by Anti-KIF3B Fab
 
Since anti-KIF3 Fab blocked axonal vesicle traffic as de-
scribed above, 
 
kif3A
 
2
 
/
 
2
 
 and 
 
kif3B
 
2
 
/
 
2
 
 embryos displayed
neuronal abnormality (Nonaka et al., 1998; Takeda et al.,
1999), and several lines of evidence implied the roles of
KIF3 in fast axonal transport (Yamazaki et al., 1995; Ray
et al., 1999), we speculated that the KIF3 motor possi-
bly  transports the components required for sprouting,
construction, and maintenance of axons, which may be
blocked by antibody microinjection, resulting in the failure
of axonal elongation. To test this hypothesis, we carried
out an experiment according to the following scheme.
Instead of microinjecting antibodies into SCG neurons
with almost fully extended processes, we now injected cells
(
 
n
 
 5 
 
60) harboring no neurites, 
 
z
 
12 h after plating. The
concentrations of Fab fragment for both anti-KIF3B anti-
body and normal mouse IgG were adjusted to 3 mg/ml. In
the case of control normal mouse IgG Fab (
 
n
 
 5 
 
50; Fig. 4,
A and B), most of the neurons developed a single axonal
structure with branching 
 
z
 
12 h after microinjection. In
many cases, axons extended to 
 
.
 
100 
 
m
 
m in length, exhibit-
ing active growth cones, and some axons were 
 
.
 
300-
 
m
 
m
long (Fig. 5). However, microinjection of anti-KIF3B Fab
blocked the sprouting of neurites (Fig. 4, C and D), leaving
most of the cells without neurites or with miniature
sproutings. The median value (Fig. 5) of the axonal sprout
length 12 h after microinjection revealed significant differ-
ences between the two groups (median values for each
Figure 2. Examples of VEC–DIC images of SCG neuronal ax-
ons. SCG neurons grown on collagen type IV-treated coverslips
were microinjected with either anti-KIF3B Fab or control normal
mouse IgG Fab, and observed under VEC–DIC z3 h after mi-
croinjection. Microinjection of anti-KIF3B Fab brought about a
decrease in the number of vesicles within the axons (A), whereas
relatively ample vesicle traffic was seen in the axons microin-
jected with normal mouse IgG Fab (B). The arrowheads depict
large vesicles; arrows indicate small vesicles. Bar, 1 mm.
Figure 3. Comparison of vesicle traffic before and after microinjection of Fabs. A, Bidirectional effect of anti-KIF3B Fab microinjec-
tion. Both antero- and retrograde traffic were inhibited by the microinjection of the Fab fragments, although the degree of inhibition of
the anterograde traffic was stronger. B, Each category of vesicles was counted by the number passing through a unit square (see Ob-
servation and Data Collection in Material and Methods, n/mm2/5 min) of axonal cross-section. A significant decrease in vesicle traffic
was recorded, except in mitochondria. Five comparisons yielded significant P values (P , 0.05; *). Bars indicate SEM. C, Normalized
vesicle traffic calibrated with that of uninjected cells. For both KIF3B Fab- and normal mouse IgG Fab-injected cells, the number of
vesicles passing through a unitary axon transverse section was divided by that in uninjected cells. Note that the injection process, per se,
did not have any deleterious effect on the vesicle traffic (the normal mouse IgG Fab group exhibited nearly 100% vesicle traffic in al-
most all subcategories, compared to the uninjected group).The Journal of Cell Biology, Volume 148, 2000 1260
group: control, 225 mm; anti-KIF3B Fab, 15 mm), implying
the role of the KIF3 motor in neurite sprouting/elonga-
tion.
KIF3 Motor Interacts with the Fodrin Molecule
We attempted to further characterize the properties of the
vesicles transported by the KIF3 complex. However, the
relatively weak and rather transient nature of the binding
between the cargos and the motor protein complex (Cole
et al., 1998) prevented us from converting real-time dy-
namic phenomena into morphological evidence. To over-
come this problem, we used the yeast two-hybrid screen-
ing. Because previous studies (Shimizu et al., 1996;
Yamazaki et al., 1996) suggested the role of KAP3 as an
associated protein of the KIF3 complex in intercalating
the motor domain and the cargos, we used a part of
the KAP3 sequence as a bait. Moreover, KAP3 has an Ar-
madillo-conserved sequence that is required for the pro-
tein–protein interaction (Gindhart and Goldstein, 1996;
Shimizu et al., 1996).
To identify the binding partner of KAP3, we generated
a fusion construct of the DNA-binding domain and KAP3
coding sequence (aa 209–384). This fusion protein was
used in yeast two-hybrid screening of mouse brain cDNA
libraries. We selected several Leu1/LacZ1 colonies from
the screening, and we isolated 17 independent positive
clones. Out of these clones, three colonies were found to
encode fragments of the fodrin gene (Fig. 6). Analysis of
the other colonies is under way to determine the in vivo
relevance of their affinity for KAP3.
Furthermore, we constructed a series of deletion mu-
tants of the KAP3 construct to determine the minimal
binding domain to the fodrin molecule (Fig. 7). The mini-
mal domain required for binding was located within the
region where the Armadillo repeat is intercepted by a
small insert (aa 209–292). In addition, we quantified the
binding affinity of each candidate molecule to KAP3 by
measuring b-galactosidase activity in liquid cultures of the
yeast. The interaction of KAP3 with a-fodrin (aII-spec-
trin) was the strongest in the three positive clones (234 U
for fodrin, 81–85 U for the other two clones, and 3 U for
the control vector; U in an arbitrary scale). Therefore, we
focused on fodrin in further experiments.
KIF3 Interacts with Fodrin on the Vesicles that Travel 
Down Axons
To confirm whether the aforementioned results in the
yeast two-hybrid assay reflected specific interaction in
vivo, we performed the following two sets of experiments.
First, we prepared vesicles from the cauda equina, which
is a thick bundle of axons, because they could be prepared
without disrupting interactions of motor with vesicles
Figure 4. Neurite sprouting was affected by microinjection of
anti-KIF3B Fab. Either anti-KIF3B Fab or normal mouse IgG
Fab was injected to the cultured SCG neurons before neurite
sprouting. Approximately 12 h after injection, the cells were
fixed and viewed by conventional fluorescence microscopy to
identify the injected cells. Then, phase-contrast images of identi-
fied cells were taken. With normal mouse IgG Fab as the nega-
tive control, A and B, the treated cells extended axons in an ordi-
nary fashion with ramification. On the contrary, microinjection
of anti-KIF3B Fab, C and D, had a drastic effect, and most of the
SCG neurons did not extend any neurites at all or exhibited only
miniature neurites. Bar, 20 mm.
Figure 5. Graphic summary for the axonal length in each experi-
mental group. Distribution of neurite length after microinjection
of anti-KIF3B Fab (black) and normal mouse IgG Fab (hatched).
Most of the SCG neurons microinjected with anti-KIF3B Fab
(n 5 60) had short axons, as represented in Fig. 4, C and D,
whereas the SCG neurons injected with normal mouse IgG Fab
extended their axon normally. The median values for each exper-
imental group show that anti-KIF3B Fab dramatically inhibited
(15 mm) axonal outgrowth, compared to normal mouse IgG Fab
(225 mm).Takeda et al. KIF3 and Axonal Transport 1261
(Okada et al., 1995b). Moreover, this source and method
enables us to isolate axonal vesicles with high purity by
detaching them from MTs in the presence of 1 mM
ATP. Therefore, we could avoid possible contaminations
of plasma membrane fragments. Immunoprecipitation of
these vesicles by using anti-KIF3B– or anti-KAP3–coated
beads gave a band that was detected with antifodrin anti-
body in Western blotting (Fig. 8 C, lanes 1 and 3). This as-
sociation was further confirmed by immunoprecipitation
with antifodrin antibody-coated beads, which could pull
down both KIF3B and KAP3 (Fig. 8, A and B, lane 5).
Furthermore, as the results of the yeast two-hybrid experi-
ment suggested, the binding of the KIF3 motor with fodrin
may be direct, since detergent solubilization after immu-
noprecipitation did not destroy the interaction between
the two molecules. In addition, immunoprecipitation by
Figure 6. Yeast two-hybrid assay of KAP3 with vesicle-associ-
ated proteins. After a yeast two-hybrid system screening, the in-
teraction of a-fodrin with KAP3 was confirmed reproducibly by
retransformation. Yeasts containing each combination of pLexA
(no insert or KAP3) and pBD42AD constructs (no insert, a-fodrin
of various lengths, aa 967–1840, 934–1267, and 1040–1323) grew
on the SD/2His/2Trp/2Ura plate containing glucose (left), al-
though those with only a-fodrin survived (right) on the selection
plate (SD/2His/2Trp/2Ura/2Leu containing galactose/raffi-
nose/X-gal/BU salts), showing blue colonies.
Figure 7. Schematic repre-
sentation of the functional
domain of KAP3 and the
a-fodrin molecule obtained
by the yeast two-hybrid sys-
tem. This scheme depicts the
entire amino acid sequence of
the KAP3 molecule (1–793).
We constructed bait vectors
of various lengths. The mini-
mal required domain for in-
teraction with fodrin con-
sisted of aa 209–292, as
indicated. Determination of
the binding affinity using liq-
uid yeast cultures was also
performed, and the results are
summarized at the right of the
figure. The minimal required
domain (209–291) showed
strongest binding affinity (in-
dicated by 11).
Figure 8. Immunoprecipita-
tion of the vesicle fraction of
cauda equina by anti-KIF3B
and KAP3 antibodies. Cauda
equina vesicles were immu-
noprecipitated with either
anti-KIF3B (lane 1), anti-
KAP3 (lane 3), anti–aII-
fodrin (lane 5), anti-KIF5A
(lane 7), or anti-KIF5B (lane
9) beads. To check the inter-
action, these immunoprecipi-
tation products were probed
with anti-KIF3B (A), anti-
KAP3 (B), anti–aII-fodrin
(C), anti-KIF5A (D), and
anti-KIF5B (E) antibodies.
Equal amounts of beads were
loaded onto the SDS gel and
analyzed by Western blot-
ting under the same condi-
tion. Note that the interac-
tion between the KIF3
complex and fodrin could be
bilaterally confirmed. Fur-
thermore, fodrin does not
associate with KIF5A or
KIF5B. In this experiment,
immunoprecipitated cauda
equina vesicles were solubi-
lized with 1% Triton X-100
for 1 h on ice. The solubiliza-
tion did not destroy the inter-
action between fodrin and
the KIF3 motor. Lanes 2, 4, 6,
8, and 10 are negative con-
trols immunoprecipitated
with the beads treated with
the preimmune serum (2, 4,
8, and 10) or normal mouse IgG (6) instead of the specific immu-
noglobulin for each antigens. Molecular weight bars (from top to
bottom): 200, 116, 97, 65, and 45 kD.The Journal of Cell Biology, Volume 148, 2000 1262
using antibodies against other KIFs, such as KIF5A and
-B, did not reveal the association of the fodrin molecule to
these motor proteins (Fig. 8 C, lanes 7 and 9), suggesting
the specific interaction of KIF3 with the fodrin molecule.
Secondly, we carried out two immunoelectron micro-
scopic experiments on the cauda equina vesicles to con-
firm morphologically the interaction between KIF3 and
fodrin. As shown in Fig. 9 F, 15.4% of the vesicles showed
both KIF3 (10-nm gold particles) and fodrin (5-nm gold
particles) labeling. In the case of single labeling for either
KIF3B or fodrin, 37.2 and 29.3% of vesicles were labeled
with the two antibodies, respectively. The size of the dou-
ble-labeled vesicles ranged from 50 to 200 nm in this
preparation (Fig. 9, A–D), which partially overlapped
with diameters of those immunoprecipitated by anti-
KIF3B immunobeads in the previous study (Yamazaki et
al., 1995). Colocalization of KIF3B and fodrin was also
confirmed in the samples embedded in 2% agarose and
epon (Fig. 9, G and H), where relatively smaller vesicles
(z30 nm) were found to be double-labeled (Fig. 9 H,
arrow).
These data collectively suggest that the interface be-
tween the KIF3 motor and cargos might be mediated by
fodrin, and those vesicles are transported as fast axonal
flow en route to the axonal plasma membrane along MT
tracks by KIF3.
Fodrin Travels Down the Axon with the KIF3 Motor
To probe the association of fodrin with the KIF3 motor in
vivo, we conducted a radiolabeled pulse–chase experiment
in the rat optic nerve. Although the same behavior of fo-
drin as the KIF3 motor within axons does not necessarily
indicate a direct association between the two proteins, and
further, with cargos by fodrin to KAP3 binding, it could be
strong evidence in this situation, since several batteries of
experiments revealed an association between the two pro-
teins.
Figure 9. Immuno-colocaliza-
tion of KIF3 and fodrin on
cauda equina vesicles. A–D,
Negatively stained cauda
equina vesicles containing
both KIF3B and fodrin. Vesi-
cles ranging from 50–200 nm
in diameter were double-
labeled (arrowheads). 10-nm
gold particles correspond to
the localization of KIF3B and
5-nm gold particles depict
aII-fodrin localization. E,
Negative control probed with
preimmune serum and nor-
mal mouse IgG, followed by
probing with the auroprobe.
No labeling was observed in
this panel, but total nonspe-
cific labeling was 4.0%. F, Di-
agram summarizing the fre-
quency of labeling for KIF3B,
fodrin, or both. About 37%
of all vesicles contained the
KIF3B labeling. G and H,
Ultrathin sections of cauda
equina vesicles labeled with
both anti-KIF3 and aII-fodrin
antibody. Compared to the
former technique, smaller
vesicles,  ,50 nm in diameter,
could be visualized to contain
the labeling (H, arrow). I,
Negative control incubated
with preimmune serum and
normal mouse IgG, followed
by the reaction with auro-
probe. Bars, 100 nm.Takeda et al. KIF3 and Axonal Transport 1263
We injected radiolabeled amino acids ([35S]methionine
and [35S]cysteine) into rat eyeballs and chased the newly
synthesized proteins by immunoprecipitation. The radiola-
beled KIF3 and fodrin moved into the optic nerve and
tract toward the lateral geniculate ganglion. Four hours af-
ter administration, neither KIF3 nor fodrin was detected
in the distal segment (10–15 mm). However, we could
identify distinct bands in the proximal segment (5–10 mm);
the velocity of fodrin transport was calculated to be be-
tween 46 and 51 mm/d (0.5–0.6 mm/sec; Fig. 10 A). Since
our previous in vitro motility assay yielded values of 0.53–
0.59 mm/s for the KIF3 motor protein (Yamazaki et al.,
1996), the obtained value here for a-fodrin velocity shows
good agreement with our previous report. The velocity of
KIF3 was also in the same range as that of fodrin, whereas
KIF1A (12–15 cm/d; 1.4–1.7 mm/sec) was much faster than
that of KIF3, confirming the satisfactory resolution and re-
liability of this method. In this regard, it should be noted
that the peaks of moving fodrin and KIF3 are not neces-
sarily the same, even in the case when KIF3 transports ves-
icles associated with fodrin, because the dynamics of fo-
drin and KIF3 in the axoplasm, such as their dissociation
and association with the vesicles, or their turnover, are
possibly different.
Discussion
Anti-KIF3B Fab Blocks Axonal
Transport Bidirectionally
We previously reported that KIF3 moves on the MT track
to its plus end (Kondo et al., 1994; Yamazaki et al., 1995),
which is considered to be an anterograde motor in neu-
ronal axons. However, in the present experiment, microin-
jection of anti-KIF3 Fab blocked vesicle transport in both
directions, although the effect was more marked on the
anterograde transport. How can we explain this seemingly
ambiguous phenomenon?
First of all, we would like to exclude the possibility of
cross-linking of the vesicles into aggregates by the injected
antibody, which would be expected to block axonal flow
nonspecifically. Retrogradely transported vesicles are es-
pecially susceptible to such physical hindrance, due to
their large size. To prevent this from occurring, we used
monovalent Fab fragments prepared from either anti-
KIF3B antibody or normal mouse IgG. Since the Fab frag-
ment has a monovalent property, possible cross-linking by
native divalent IgG is avoided. In addition, the more
marked inhibition of anterograde transport is also not con-
sistent with this possibility.
Secondly, considering the equilibrium of the membrane
pool within axons, it is quite reasonable to speculate that
the decreased supply of membranous components to the
distal tip of the axon resulted in the reduction of the back-
flow. Technically speaking, it is also possible that some
types of motor proteins responsible for retrograde trans-
port are also attached to the surfaces of vesicles conveyed
by the KIF3 complex, so that backflow is also affected
in a somewhat indirect manner. Although there are sev-
eral lines of evidence suggesting that cytoplasmic dynein
(CyDy) interacts with fodrin via the dynactin complex
(Holleran et al., 1996) and is indispensable for axonal
transport (Dillman et al., 1996; Waterman-Storer et al.,
1997), we could not directly prove any interaction between
KIF3 and CyDy by immunoprecipitation techniques and
conventional immunofluorescence microscopy. To date, it
is not clear whether the KIF3 motor also conveys a part of
the dynein/dynactin complex; some species of anterograde
motors probably also carry retrograde motors, such as
CyDy, since there is no protein synthesis machinery at the
distal end of the axon. Indeed, our previous immuno-
cytochemical study in ligated nerves revealed accumula-
tion of CyDy on both sides of the ligature (Hirokawa et
al., 1990). Moreover, recently reported evidence impli-
cates strong dominant genetic interactions among kinesin,
CyDy, and dynactin complex mutations in axonal trans-
port in Drosophila (Martin et al., 1999). Although it is still
premature to presume a similar relationship between
KIF3 and CyDy, it might provide a toehold for clarifying
the mechanism underlying the bidirectional inhibition.
Finally, it should be noted that as the resolution of
VEC–DIC is not sufficient for the complete visualization
of all vesicles. The transport of other smaller vesicles or
protein complexes that might not be captured by VEC–
DIC may also be affected by anti-KIF3 Fab microinjec-
tion.
Interrelationship among the KIF3 Motor, Intracellular 
Transport, and Neurite Sprouting: Implications from 
our Study
Another remarkable result presented in this study is the
inhibition of neurite sprouting and neurite extension by
anti-KIF3 Fab injection, the data being consistent with the
knowledge that fast axonal transport is required for the
advancement of the growth cone (Martenson et al., 1993).
Figure 10. Pulse-labeling
study revealing the velocity
of KIF3, KIF1A, and fodrin
in the rat optic nerve. A,
[35S]methionine was injected
into the vitreous. 4, 6, and 8 h
after administration, the op-
tic nerve and tract were extir-
pated en bloc and further cut
into consecutive 5-mm seg-
ments. The second (5–10
mm) and third (10–15 mm)
segments were used for the
analyses. Note that KIF3 and
fodrin bands begin to appear
6 h after treatment. B, Since
the reported velocity of
KIF1A is much higher than
that of KIF3, we killed the
animals earlier for determi-
nation of the former. In this
case, the time of appearance
of the KIF1A bands shows
good agreement with previ-
ous in vitro data, confirming
the appropriateness of this system for roughly estimating the ve-
locity of axonal transport. CE, Crude extract; IP, immunoprecipi-
tation.The Journal of Cell Biology, Volume 148, 2000 1264
In addition, as Bamburg et al. (1986) reported complete
inhibition of axonal growth occurred in the DRG after ad-
ministration of colcemid, our results also support the
assumption that MT-dependent axonal transport is in-
dispensable for the axonal sprouting/elongation process.
Taken together, it is reasonable to consider that the KIF3
motor may be involved in axonal sprouting events by sup-
plying materials where they are required. Then, how can
we explain the relationship between neurite extension and
a cargo of the KIF3 motor? We would like to discuss this
material in two directions: vesicular traffic from the Golgi
complex to the axonal plasma membrane; and fodrin mol-
ecule and neurite sprouting.
As previously reported (Le Bot et al., 1998), the KIF3
motor localizes on the Golgi complex and is responsible
for Golgi complex to ER traffic. In our preliminary study,
using the Golgi complex preparation from the rat liver
(data not shown), KIF3 molecules colocalized with the fo-
drin molecule on the budding vesicles from the trans-sur-
face of the Golgi complex. Moreover, we immunoprecipi-
tated fodrin with the anti-KIF3 antibody from a vesicle
fraction of the cauda equina. The possibility must be con-
sidered that KIF3 conveys proteins modified at the Golgi
complex and contained in the vesicles pinched off from it
to the axonal tips. The colocalization of KIF3B with fodrin
on identical vesicles of the cauda equina (Fig. 9, A–D) de
facto implies that the situation is analogous with that of
CyDy (Holleran et al., 1996). In the case of CyDy, the
so-called dynein–dynactin complex binds to the vesicles
through the interface between Arp1 and spectrin (fodrin).
Although it is not clear whether other components are
present in the KIF3 motor, as is the case for CyDy, it could
be stated that some vesicles containing fodrin derived
from the Golgi complex are transported by the KIF3 mo-
tor using the fodrin molecule as a linker protein. Then,
they are transported by the KIF3 motor along axonal MTs
as a fast component (Cheney et al., 1983), inserted and in-
corporated into the axonal plasma membrane and cyto-
skeletal architecture underneath the plasma membrane,
because fodrin, together with actin, constitutes the major
component of the subaxolemmal cytoskeletal network
(Levine and Willard, 1981; Hirokawa, 1982).
From another standpoint, it is plausible that impaired
transport of the fodrin molecule, per se, by the KIF3 mo-
tor might bring about inhibition of neurite extension. As
reported previously, fodrin is concentrated at the growth
cone (Sobue and Kanda, 1989), subaxolemmal region (Le-
vine and Willard, 1981), and the abnormally sprouting
neurons in Alzheimer’s disease (Masliah et al., 1991). In
particular, taking the experimental data that fodrin is lo-
calized within adhesive sites of growth cone (Sobue and
Kanda, 1989) into account, inhibition of axonal elongation
could be attributed to the lack of the adhesiveness that
generates the traction force for the advancement of the
growth cone. Alternatively, miniature sprouting (Fig. 4 C,
D) could be a result of subaxolemmal instability, due to
the absence of fodrin molecules. For example, a-spectrin
mutants of Drosophila exhibited pronounced morphologi-
cal changes in their complex cytoarchitecture, such as in
the brush borders of the midgut epithelia (Lee et al.,
1993). As the cytoskeletal architecture of the growth cone
lamellipodia is similar in certain aspects to that of the
brush border, where fodrin and actin constitute the major
components of the subplasmalemmal cytoskeletal network
(Hirokawa et al., 1983), it is plausible that the phenotype is
shared by the two different species and cells. This implies a
certain kind of common mechanism controlling motile cel-
lular structure conserved among species. 
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